Home - National Multiple Sclerosis Society

Skip to navigation Skip to content

Protect the MS Research Program at the Department of Defense

Urge your U.S. Senators to support the bipartisan Durbin-Blunt Amendment to the National Defense Authorization Act (S.1519). This Amendment will remove language that threatens the Congressionally Directed Medical Research Programs, including the Multiple Sclerosis Research Program. This innovative medical research is critical to moving us one step closer to a world free of MS!

Recipients

  • Your Senators

Contact

*Required fields
 
 

Message

Support the Durbin-Blunt Amendment to the National Defense Authorization Act (NDAA)

Dear [Decision Maker],

As your constituent and as an MS activist, I urge you to support the Durbin-Blunt Amendment to protect the Congressionally Directed Medical Research Programs at the Department of Defense. The CDMRP fills research gaps by funding high impact, high-risk and high gain projects that other research agencies like the National Institutes of Health may not fund. The MS Research Program (MSRP) examines gaps in knowledge about the biological basis of disease progression, diagnosis and treatment, and biomarkers for preclinical detection.



Sections 733, 891, 892, 893 of the FY 2018 National Defense Authorization Act (NDAA, S. 1519) threaten the existence of these important programs and would place burdensome requirements on them that do not exist for any other medical research grant in the federal government. Senators Blunt (R-MO) and Durbin (D-IL) are leading a bipartisan group of Senators to remove these harmful sections from the NDAA.

Removing this harmful language from the NDAA is crucial to protecting the MSRP and all medical research within the DoD. Innovative medical research is one step in leading us closer to a world free of MS!

Sincerely,